›› 2016, Vol. 34 ›› Issue (12): 881-.doi: 10.3969/j.issn.1000-3606.2016.12.001
Next Articles
WANG Limin1 , ZHAO Yiming1 , LYU Xiumin1 , LI Guimei2
Received:
Online:
Published:
Abstract: Objective To observe the changes of adrenal cortical function in children with growth hormone deficiency before and after treatment with recombinant human growth hormone. Methods Seventy-two children diagnosed with GHD who received rhGH treatment for no less than 6 month were included, among whom there were 32 children who were accompanied with adrenal cortical hormone (ACTH) deficiency. The changes of fasting plasma cortisol (COR) and ACTH levels before and 3 and 6 months after treatment with rhGH were retrospectively analyzed. Results Thirty-two children with ACTH deficiency were treated with rhGH after COR level reached normal by the supplementing exogenous hydrocortisone. There was negative correlation between COR level before treatment and the HC dose that make the COR reach normal lowest limit level (r?=?-0.899, P?0.01). One month after HC treatment only, the level of COR was obviously increased and ACTH was obviously decreased (P all?0.001). The levels of COR or ACTH at 3 or 6 months after rhGH and HC replacement therapy were not different from those at one month after HC treatment only (P all?>?0.05). The level of COR was obviously decreased after treatment with rhGH, and there was statistical difference compared with that before treatment (P?0.01) in 40 children without ACTH deficiency, among whom 10 children with abnormal hypothalamic pituitary MRI had lower level of COR. Conclusion Adrenal cortical function can be reduced during the treatment with rhGH in children with GHD, especially in children with abnormal hypophysis MRI. Thus, during the treatment period, adrenal cortical function should be monitored, so as to make early intervention.
WANG Limin,ZHAO Yiming,LYU Xiumin,LI Guimei. Changes of adrenal cortical function in children with growth hormone deficiency before and after treatment with recombinant human growth hormone[J]., 2016, 34(12): 881-.
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: https://jcp.xinhuamed.com.cn/EN/10.3969/j.issn.1000-3606.2016.12.001
https://jcp.xinhuamed.com.cn/EN/Y2016/V34/I12/881
Cited